Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells

<h4>Background</h4> Delivery of CRISPR/Cas RNPs to target cells still remains the biggest bottleneck to genome editing. Many efforts are made to develop efficient CRISPR/Cas RNP delivery methods that will not affect viability of target cell dramatically. Popular current methods and proto...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marina A. Tyumentseva, Aleksandr I. Tyumentsev, Vasiliy G. Akimkin
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/29be6d3838f34a0492e637a62af0d06e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:29be6d3838f34a0492e637a62af0d06e
record_format dspace
spelling oai:doaj.org-article:29be6d3838f34a0492e637a62af0d06e2021-11-18T06:34:24ZProtocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells1932-6203https://doaj.org/article/29be6d3838f34a0492e637a62af0d06e2021-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577758/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4> Delivery of CRISPR/Cas RNPs to target cells still remains the biggest bottleneck to genome editing. Many efforts are made to develop efficient CRISPR/Cas RNP delivery methods that will not affect viability of target cell dramatically. Popular current methods and protocols of CRISPR/Cas RNP delivery include lipofection and electroporation, transduction by osmocytosis and reversible permeabilization and erythrocyte-based methods. <h4>Methods</h4> In this study we will assess the efficiency and optimize current CRISPR/Cas RNP delivery protocols to target cells. We will conduct our work using molecular cloning, protein expression and purification, cell culture, flow cytometry (immunocytochemistry) and cellular imaging techniques. <h4>Discussion</h4> This will be the first extensive comparative study of popular current methods and protocols of CRISPR/Cas RNP delivery to human cell lines and primary cells. All protocols will be optimized and characterized using the following criteria i) protein delivery and genome editing efficacy; ii) viability of target cells after delivery (post-transduction recovery); iii) scalability of delivery process; iv) cost-effectiveness of the delivery process and v) intellectual property rights. Some methods will be considered ‘research-use only’, others will be recommended for scaling and application in the development of cell-based therapies.Marina A. TyumentsevaAleksandr I. TyumentsevVasiliy G. AkimkinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marina A. Tyumentseva
Aleksandr I. Tyumentsev
Vasiliy G. Akimkin
Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
description <h4>Background</h4> Delivery of CRISPR/Cas RNPs to target cells still remains the biggest bottleneck to genome editing. Many efforts are made to develop efficient CRISPR/Cas RNP delivery methods that will not affect viability of target cell dramatically. Popular current methods and protocols of CRISPR/Cas RNP delivery include lipofection and electroporation, transduction by osmocytosis and reversible permeabilization and erythrocyte-based methods. <h4>Methods</h4> In this study we will assess the efficiency and optimize current CRISPR/Cas RNP delivery protocols to target cells. We will conduct our work using molecular cloning, protein expression and purification, cell culture, flow cytometry (immunocytochemistry) and cellular imaging techniques. <h4>Discussion</h4> This will be the first extensive comparative study of popular current methods and protocols of CRISPR/Cas RNP delivery to human cell lines and primary cells. All protocols will be optimized and characterized using the following criteria i) protein delivery and genome editing efficacy; ii) viability of target cells after delivery (post-transduction recovery); iii) scalability of delivery process; iv) cost-effectiveness of the delivery process and v) intellectual property rights. Some methods will be considered ‘research-use only’, others will be recommended for scaling and application in the development of cell-based therapies.
format article
author Marina A. Tyumentseva
Aleksandr I. Tyumentsev
Vasiliy G. Akimkin
author_facet Marina A. Tyumentseva
Aleksandr I. Tyumentsev
Vasiliy G. Akimkin
author_sort Marina A. Tyumentseva
title Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
title_short Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
title_full Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
title_fullStr Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
title_full_unstemmed Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
title_sort protocol for assessment of the efficiency of crispr/cas rnp delivery to different types of target cells
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/29be6d3838f34a0492e637a62af0d06e
work_keys_str_mv AT marinaatyumentseva protocolforassessmentoftheefficiencyofcrisprcasrnpdeliverytodifferenttypesoftargetcells
AT aleksandrityumentsev protocolforassessmentoftheefficiencyofcrisprcasrnpdeliverytodifferenttypesoftargetcells
AT vasiliygakimkin protocolforassessmentoftheefficiencyofcrisprcasrnpdeliverytodifferenttypesoftargetcells
_version_ 1718424467782238208